| HIV-1 nomenclature proposal DL Robertson, JP Anderson, JA Bradac, JK Carr, B Foley, RK Funkhouser, ... Science 288 (5463), 55-55, 2000 | 1469 | 2000 |
| HIV surveillance--United States, 1981-2008 Centers for Disease Control and Prevention (CDC MMWR. Morbidity and mortality weekly report 60 (21), 689-693, 2011 | 362* | 2011 |
| Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, US–2006 WH Wheeler, RA Ziebell, H Zabina, D Pieniazek, J Prejean, UR Bodnar, ... Aids 24 (8), 1203-1212, 2010 | 275 | 2010 |
| Protease sequences from HIV-1 group M subtypes A–H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals … D Pieniazek, M Rayfield, DJ Hu, J Nkengasong, SZ Wiktor, R Downing, ... Aids 14 (11), 1489-1495, 2000 | 177 | 2000 |
| Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil. A Ramos, A Tanuri, M Schechter, MA Rayfield, DJ Hu, MC Cabral, ... Emerging infectious diseases 5 (1), 65, 1999 | 133 | 1999 |
| Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes WM Switzer, D Pieniazek, P Swanson, HH Samdal, V Soriano, ... Journal of Virology 69 (2), 621-632, 1995 | 113 | 1995 |
| Recombinant viruses and early global HIV-1 epidemic ML Kalish, KE Robbins, D Pieniazek, A Schaefer, N Nzilambi, TC Quinn, ... Emerging infectious diseases 10 (7), 1227, 2004 | 108 | 2004 |
| Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers C Yang, D Pieniazek, SM Owen, C Fridlund, J Nkengasong, TD Mastro, ... Journal of clinical microbiology 37 (8), 2581-2586, 1999 | 91 | 1999 |
| Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis LM Janini, D Pieniazek, JM Peralta, M Schechter, A Tanuri, ACP Vicente, ... Virus Genes 13, 69-81, 1996 | 88 | 1996 |
| HIV-1 group O virus identified for the first time in the United States. MA Rayfield, P Sullivan, CI Bandea, L Britvan, RA Otten, CP Pau, ... Emerging infectious diseases 2 (3), 209, 1996 | 87 | 1996 |
| Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A NR Faria, I Hodges-Mameletzis, JC Silva, B Rodés, S Erasmus, ... Journal of General Virology 93 (4), 889-899, 2012 | 85 | 2012 |
| Identification of mixed HIV-1/HIV-2 infections in Brazil by polymerase chain reaction D Pieniazek, JM Peralta, JA Ferreira, JW Krebs, SM Owen, FS Sion, ... Aids 5 (11), 1293-1300, 1991 | 85 | 1991 |
| Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast D Pieniazek, D Ellenberger, LM Janini, AC Ramos, J Nkengasong, ... AIDS research and human retroviruses 15 (6), 603-608, 1999 | 81 | 1999 |
| HIV-1 subtypes among blood donors from Rio de Janeiro, Brazil A Tanuri, P Swanson, S Devare, OJ Berro, A Savedra, LJ Costa, JG Telles, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 20 (1), 60-66, 1999 | 81 | 1999 |
| Human adenovirus type 41 contains two fibers Y Hung-Yueh, N Pieniazek, D Pieniazek, H Gelderblom, RB Luftig Virus research 33 (2), 179-198, 1994 | 81 | 1994 |
| Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C LM Janini, A Tanuri, M Schechter, JM Peralta, ACP Vicente, ND Torre, ... Journal of Infectious Diseases 177 (1), 227-231, 1998 | 77 | 1998 |
| Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil A Tanuri, ACP Vicente, K Otsuki, CA Ramos, OC Ferreira Jr, M Schechter, ... Antimicrobial agents and chemotherapy 43 (2), 253-258, 1999 | 71 | 1999 |
| A molecular epidemiologic survey of HIV in Uganda MA Rayfield, RG Downing, J Baggs, DJ Hu, D Pieniazek, CC Luo, ... Aids 12 (5), 521-527, 1998 | 70 | 1998 |
| Human immunodeficiency virus type 1 group M protease in Cameroon: genetic diversity and protease inhibitor mutational features PN Fonjungo, EN Mpoudi, JN Torimiro, GA Alemnji, LT Eno, EJ Lyonga, ... Journal of clinical microbiology 40 (3), 837-845, 2002 | 65 | 2002 |
| Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro … AT Dumans, MA Soares, D Pieniazek, ML Kalish, V De Vroey, K Hertogs, ... Antimicrobial agents and chemotherapy 46 (9), 3075-3079, 2002 | 61 | 2002 |
